drugset
drugset / Trial / NCT02267226

Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

NCT02267226 ↗

Phase 3 Completed 25 enrolled Octapharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the efficacy and safety of Octafibrin for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency.

Timeline

Start
2014-09
Primary completion
2018-02-14
Completion
2018-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Octafibrin Protein / enzyme biologic — —

Indications

congenital fibrinogen deficiency